SHL Telemedicine: Half-year results 2023 and Conference Call Scheduled for September 21, 2023
- None.
- None.
The conference call for investors, journalists, and analysts to discuss the half-year results 2023 will be hosted by Erez Nachtomy, CEO, and Amir Hai, CFO, and has been scheduled for:
Date: Thursday, 21 September 2023
Time: 4 pm CET / 10 am ET / 5 pm Israel Time
The conference call can be accessed live via the dial-in numbers:
From
From the
From the
From
Toll free: 1 80 921 44 27
Local: +972 3763 1173
Other international numbers are available here.
After the presentation, there will be an open Q&A. The conference call is scheduled to last 40-60 minutes and will be held in English.
The press release and the presentation slides will be made available at the company website www.shl-telemedicine.com at 7.00 am CET on 21 September 2023.
About SHL Telemedicine
SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and on the Nasdaq Stock Exchange (SHLT, ISIN: US78423T2006, CUSIP: 78423T200). For more information, please visit our website at www.shl-telemedicine.com.
Logo: https://mma.prnewswire.com/media/1850421/SHL_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/shl-telemedicine-half-year-results-2023-and-conference-call-scheduled-for-september-21-2023-301919050.html
SOURCE SHL Telemedicine Ltd.
